Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention.

Left ventricular volumes and mass in marathon runners and their association with cardiovascular risk factors. Int J Cardiovasc Imaging (2008) 1.47

Participation and performance trends in ultra-endurance running races under extreme conditions - 'Spartathlon' versus 'Badwater'. Extrem Physiol Med (2013) 1.01

Competing risks of mortality with marathons: retrospective analysis. BMJ (2007) 0.97

The pre-participation examination for leisure time physical activity: general medical and cardiological issues. Dtsch Arztebl Int (2010) 0.93

Indirect catastrophic injuries in olympic styles of wrestling in iran. Sports Health (2011) 0.91

Cerebral vasomotor reactivity during hypo- and hypercapnia in sedentary elderly and Masters athletes. J Cereb Blood Flow Metab (2013) 0.86

Lower prevalence of hypertension, hypercholesterolemia, and diabetes in marathoners. Med Sci Sports Exerc (2009) 0.86

Role of exercise stress test in master athletes. Br J Sports Med (2005) 0.85

Cardiac risk of coronary patients after reintegration into occupations with heavy physical exertion. Z Kardiol (2005) 0.78

Cardiovascular prevention in a high risk sport, ice hockey: applications in wider sports physical therapy practice. N Am J Sports Phys Ther (2006) 0.77

Screening athletes for heart disease. Heart (2007) 0.76

The Masters Athlete: A Review of Current Exercise and Treatment Recommendations. Sports Health (2015) 0.75

Application of pre-participation cardiovascular screening guidelines to novice older runners and endurance athletes. SAGE Open Med (2016) 0.75

Soccer related sudden deaths in Turkey. J Sports Sci Med (2008) 0.75

Cardiovascular Risk and Disease Among Masters Endurance Athletes: Insights from the Boston MASTER (Masters Athletes Survey To Evaluate Risk) Initiative. Sports Med Open (2016) 0.75

Internet Survey: Health Screening in Sports. J Atr Fibrillation (2016) 0.75

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation (2009) 35.24

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA (2001) 9.16

Corticocortical inhibition in human motor cortex. J Physiol (1993) 8.92

Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol (2000) 7.39

Physical activity and the incidence of coronary heart disease. Annu Rev Public Health (1987) 6.76

Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science (1998) 5.98

Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69

Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 5.08

An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis) N Engl J Med (1998) 4.92

AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation (2000) 4.80

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med (1998) 4.29

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res (1998) 4.27

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16

The management of hypertrophic cardiomyopathy. N Engl J Med (1997) 4.15

Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med (1989) 4.02

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med (2000) 3.99

Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation (1993) 3.94

Profile of preparticipation cardiovascular screening for high school athletes. JAMA (1998) 3.36

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation (1998) 3.18

The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med (1991) 3.17

Stimulation of the human motor cortex through the scalp. Exp Physiol (1991) 3.16

ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14

Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries. Circulation (1976) 3.11

Sudden death in young athletes. Circulation (1980) 3.05

AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation (2000) 3.05

Age and gender comparisons of muscle strength in 654 women and men aged 20-93 yr. J Appl Physiol (1985) (1997) 3.05

Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.97

Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88

Idiopathic short QT interval: a new clinical syndrome? Cardiology (2000) 2.85

Motor cortex stimulation in intact man. 2. Multiple descending volleys. Brain (1987) 2.77

Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J (2002) 2.75

Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry (1988) 2.74

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. N Engl J Med (1990) 2.73

Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation (1979) 2.68

Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation (1996) 2.67

Human walking and higher-level gait disorders, particularly in the elderly. Neurology (1993) 2.65

Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA (1982) 2.62

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol (1995) 2.62

The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol (1999) 2.56

Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56

AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation (2001) 2.51

The pathophysiology of primary dystonia. Brain (1998) 2.51

The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol (1998) 2.38

A study of hereditary essential tremor. Brain (1994) 2.37

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37

Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry (1986) 2.37

Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36

Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology (1992) 2.36

Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation (1996) 2.34

Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33

Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol (1985) (1999) 2.31

Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J (2001) 2.30

Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30

Abnormalities in central motor pathway conduction in multiple sclerosis. Lancet (1984) 2.30

Exercise as cardiovascular therapy. Circulation (1999) 2.29

Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27

Long-lasting sport practice and lone atrial fibrillation. Eur Heart J (2002) 2.26

Pathophysiology of bradykinesia in Parkinson's disease. Brain (2001) 2.24

Prognosis of surgically corrected coarctation of the aorta. A 20-year postoperative appraisal. Circulation (1973) 2.21

Delay in the execution of voluntary movement by electrical or magnetic brain stimulation in intact man. Evidence for the storage of motor programs in the brain. Brain (1989) 2.19

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18

Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18

The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med (2000) 2.11

Assessing VO2max in epidemiologic studies: modification of the Astrand-Rhyming test. Med Sci Sports Exerc (1982) 2.11

Myonecrosis after revascularization procedures. J Am Coll Cardiol (1998) 2.11

Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA (2000) 2.10

Corticobasal degeneration. A clinical study of 36 cases. Brain (1994) 2.10

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08

Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation (1998) 2.06

Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med (1999) 2.05

Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el Síndrome Coronario Agudo y Tiempo de Espera. JAMA (1998) 2.04

Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation (2000) 2.03

Modulation of motor cortical excitability by electrical stimulation over the cerebellum in man. J Physiol (1991) 2.01

Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med (1986) 2.00

Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation (2001) 2.00

Motor cortex stimulation in intact man. 1. General characteristics of EMG responses in different muscles. Brain (1987) 1.98

An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health (2003) 1.96

Percutaneous electrical stimulation of corticospinal pathways at the level of the pyramidal decussation in humans. Ann Neurol (1991) 1.93

Assessing tremor severity. J Neurol Neurosurg Psychiatry (1993) 1.92

Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol (1984) 1.91

Effect of vision and stance width on human body motion when standing: implications for afferent control of lateral sway. J Physiol (1993) 1.91

AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke (2000) 1.90

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol (1981) 1.89

Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation (1982) 1.87

Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation (1994) 1.86

American College of Sports Medicine position stand. Heat and cold illnesses during distance running. Med Sci Sports Exerc (1996) 1.86

Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85

Congenital coronary artery anomalies in young patients: new perspectives for timely identification. J Am Coll Cardiol (2001) 1.84

Different sites of action of electrical and magnetic stimulation of the human brain. Neurosci Lett (1987) 1.84

ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation (1997) 1.83

Reciprocal inhibition between forearm muscles in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke. Brain (1989) 1.83

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81

Cardiovascular benefits and assessment of physical activity and physical fitness in adults. Med Sci Sports Exerc (1992) 1.81